Literature DB >> 21771646

Development of a serum-free human cornea construct for in vitro drug absorption studies: the influence of varying cultivation parameters on barrier characteristics.

Matthias Hahne1, Stephan Reichl.   

Abstract

The increased use of ophthalmic products in recent years has led to an increased demand for in vitro and in vivo transcorneal drug absorption studies. Cell-culture models of the human cornea can avoid several of the disadvantages of widely used animal experimental models, including ethical concerns and poor standardisation. This study describes the development of a serum-free cultivated, three-dimensional human cornea model (Hemicornea, HC) for drug absorption experiments. The impact of varying cultivation conditions on the corneal barrier function was analysed and compared with excised rabbit and porcine corneas. The HC was cultivated on permeable polycarbonate filters using immortalised human keratocytes and a corneal epithelial cell line. The equivalence to native tissue was investigated through absorption studies using model substances with a wide range of molecular characteristics, including hydrophilic sodium fluorescein, lipophilic rhodamine B and fluorescein isothiocyanate (FITC)-labelled macromolecule dextran. To study the intra-laboratory repeatability and construct cultivation, the permeation studies were performed independently by different researchers. The HC exhibited a permeation barrier in the same range as excised animal corneas, high reproducibility and a lower standard deviation. Therefore, the HC could be a promising in vitro alternative to ex vivo corneal tissues in preclinical permeation studies.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21771646     DOI: 10.1016/j.ijpharm.2011.07.004

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  New Classes of Polycationic Compounds as Preservatives for Ophthalmic Formulations.

Authors:  Dörte von Deylen; Christina Dreher; Oliver Seidelmann; Stephan Reichl
Journal:  Pharm Res       Date:  2018-11-08       Impact factor: 4.200

2.  mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs.

Authors:  Christian Kölln; Stephan Reichl
Journal:  J Ocul Pharmacol Ther       Date:  2011-12-23       Impact factor: 2.671

3.  Development of In Vitro Methodologies to Investigate Binding by Sodium Hyaluronate in Eye Drops to Corneal Surfaces.

Authors:  Udo Bock; Von Deylen D; Jochner M; Doerr M; Stäbler C; Reichl S
Journal:  Open Ophthalmol J       Date:  2018-07-31

Review 4.  The Human Tissue-Engineered Cornea (hTEC): Recent Progress.

Authors:  Louis-Philippe Guérin; Gaëtan Le-Bel; Pascale Desjardins; Camille Couture; Elodie Gillard; Élodie Boisselier; Richard Bazin; Lucie Germain; Sylvain L Guérin
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.